Over-expression of heparanase promotes proliferation and migration of gallbladder cancer cell line GBC-SD

Abstract

Abstract: Objective To investigate the effect of heparanase over-expression on the biological function of gallbladder carcinoma cell line GBC-SD. Methods The heparanase over-expression plasmid vector was constructed and transfected into GBC-SD cells by liposome method. The transfection efficiency was verified by RT-qPCR and Western blot. CCK-8 assay, flow cytometry and scratch healing experiment were used to detect the cell proliferation, apoptosis and migration.The expression of syndecan-1, FGF-2 and E-cadherin protein was detected by Western blot. Results The expression of heparanase mRNA(P＜0.01) and protein(P＜0.05) in gallbladder cancer cell line GBC-SD was significantly increased after transfection.Compared with the control group,the over-expression of heparanase significantly up-regulated the proliferation and migration ability of GBC-SD cells in vitro(P＜0.05), down-regulated the level of apoptosis(P＜0.05),and increased the expression of FGF-2 protein, while decreasing the expression of syndecan-1(P＜0.01) and E-cadherin(P＜0.05). Conclusions Over-expression of heparanase promotes the proliferation and migration of gallbladder cancer cell line GBC-SD, and the mechanism may be related to its regulation of E-cadherin through FGF-2.

Key words: gallbladder carcinoma, heparanase, proliferation, apoptosis, migration

CLC Number:

R735.8

LIU Zi-xiang, ZHOU Shao-bo, ZHANG Zi-yan. Over-expression of heparanase promotes proliferation and migration of gallbladder cancer cell line GBC-SD[J]. Basic & Clinical Medicine, 2020, 40(2): 198-202.

References

[1]Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome [J]. Clin Epidemiol, 2014, 6: 99-109.
[2]Siegel RL, Fedewa SA, Miller KD, et al. Cancer statistics for Hispanics/Latinos, 2015 [J]. CA Cancer J Clin, 2015, 65: 457-480.
[3]Masola V, Gambaro G, Tibaldi E, et al. Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells [J]. J Biol Chem, 2012, 287: 1478-1488.
[4]Liu LP, Sheng XP, Shuai TK, et al. Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression [J]. World J Gastroenterol, 2018, 24: 4565-4577.
[5]Chen X, Jiang W, Yue C, et al. Heparanase contributes to trans-endothelial migration of hepatocellular carcinoma cells [J]. J Cancer, 2017, 8: 3309-3317.
[6]Song JW, Tan YX, Li SB, et al. Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling [J]. Oncotarget, 2017, 8: 58417-58429.
[7]Jin H, Zhou S, Yang S, et al. Heparanase overexpression down-regulates syndecan-1 expression in a gallbladder carcinoma cell line [J]. J Int Med Res, 2017, 45: 662-672.
[8]Rivara S, Milazzo FM, Giannini G. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases [J]. Future Med Chem, 2016, 8: 647-680.
[9]Wang L, Huang X, Kong G, et al. Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS [J]. Biochem Biophys Res Commun, 2016, 478: 669-675.
[10]Vlodavsky I, Miao HQ, Medalion B, et al. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor [J]. Cancer Metastasis Rev, 1996, 15: 177-186.
[11]Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, et al. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism [J]. Trends Biochem Sci, 1991, 16: 268-271.
[12]Secchi MF, Masola V, Zaza G, et al. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer [J]. Biomol Concepts, 2015, 6: 415-421.
[13]Strutz F, Zeisberg M, Ziyadeh FN, et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation [J]. Kidney Int, 2002, 61: 1714-1728.

[1]	LUO Menglin, ZHENG Feng, JI Xinyao, QI Caihong, XIAO Yuheng, NIU Changchun. Fluid shear promotes apoptosis of glomerular endothelial cells by activation of Piezo 1 [J]. Basic & Clinical Medicine, 2024, 44(9): 1236-1242.
[2]	XIAO Yanhong, JIANG Mingdong, LIN Yeyuan, RAN Can, LIANG Bo. Scutellarin inhibits proliferation and migration of human prostate cancer cell line PC-3 [J]. Basic & Clinical Medicine, 2024, 44(9): 1229-1235.
[3]	WANG Tingting, WEI Huan, YANG Yongli, ZHOU Xian, HU Yang. Nervous protection provided by notoginsenoside Rg1 in rat model with Alzheimer′s disease [J]. Basic & Clinical Medicine, 2024, 44(8): 1094-1100.
[4]	GAO Chao, ZHANG Runhan, WANG Wei, ZHAO Manting, JIAO Yan, LI Zhe. Effect of artesunate on neuroinflammation in depressed mouse model by regulating cGAS-STING signaling pathway [J]. Basic & Clinical Medicine, 2024, 44(8): 1126-1132.
[5]	YU Dongling, MO Shaoe, FU Wen, CHEN Shi, XIE Chouqin, LAN Yuyan. Inhibition of sigma-1 receptor reduces DRG cell apoptosis of rats with neuropathic pain [J]. Basic & Clinical Medicine, 2024, 44(8): 1101-1106.
[6]	YAO Anjun, CHEN Lingzi, JIN Huixian. Docosahexaenoic acid inhibits proliferation of human colon cancer cell line HT-29 [J]. Basic & Clinical Medicine, 2024, 44(8): 1107-1112.
[7]	ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan. Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549 [J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
[8]	CAO Qingwen, QI Lin, YU Bo, TIAN Chenchen, YUAN Haining, WANG Yue. Salidroside promotes proliferation and migration of human vascular endothelial cell line EA.hy926 [J]. Basic & Clinical Medicine, 2024, 44(7): 925-930.
[9]	ZHANG Pengju, LI Jie, ZHANG Mengdi, SUN Shaoke, XU Yinzhe. KAT8 promotes the proliferation of colorectal cancer cell lines by enhancing METTL3 expression [J]. Basic & Clinical Medicine, 2024, 44(7): 931-939.
[10]	GAO Yinjie, TONG Anli. Mechanisms of cell death and proliferation of aldosterone-producing adenoma [J]. Basic & Clinical Medicine, 2024, 44(6): 758-762.
[11]	LI Jinping, LIU Hanqing, YANG Quanhui. Change of cell cycle in rat spleen after severe abdominal infection [J]. Basic & Clinical Medicine, 2024, 44(6): 828-832.
[12]	GONG Jintao, LI Jianwei, LI Yuheng, LI Qian, ZHAO Chunhua. Bone marrow-derived mesenchymal stem cells relieve the adverse effects of simulated microgravity on mouse cerebral cortex [J]. Basic & Clinical Medicine, 2024, 44(6): 772-778.
[13]	WANG Tingting, XIAO Ning, LIN Dianxin, DONG Haitao. Allicin inhibits the proliferation of oral cancer cells line CAL27 [J]. Basic & Clinical Medicine, 2024, 44(5): 673-676.
[14]	JIA Anna, GUO Jinxin, ZHANG Xuan, ZHAN Shijia, YU Yongbo, GUO Yongli, CHANG Yan. Regulation of TMEFF1 on proliferation of neuroblastoma cell lines [J]. Basic & Clinical Medicine, 2024, 44(5): 637-644.
[15]	SONG Ke, SONG Ke, LI Jingyu, MA Wei, YANG Xiaokui. Protein expression and subcellular distribution of centriolar component SAS-6 in mouse oocyte meiosis [J]. Basic & Clinical Medicine, 2024, 44(5): 651-657.